Completed

Psychosocial Treatment for ADHD Inattentive Type I

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Attention Deficit Disorder with Hyperactivity+5

+ Mental Disorders

+ Hyperkinesis

From 7 to 11 Years
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: September 2002
See protocol details

Summary

Principal SponsorUniversity of California, San Francisco
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2002

Actual date on which the first participant was enrolled.

ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed. Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.

Official TitlePsychosocial Treatment for ADHD Inattentive Type I 
NCT00071656
Principal SponsorUniversity of California, San Francisco
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 7 to 11 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Attention Deficit Disorder with HyperactivityMental DisordersHyperkinesisNervous System DiseasesNeurologic ManifestationsAttention Deficit and Disruptive Behavior DisordersDyskinesiasNeurodevelopmental Disorders

Criteria

Inclusion Criteria: * ADHD, Predominantly Inattentive Type * Public or private school attendance * English speaking

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

HALP Clinic, Children's Center at Langley Porter, UCSF

San Francisco, United StatesSee the location
CompletedOne Study Center